Phase 2 N=14 Acamprosate in Youth With Fragile X Syndrome
Fragile X Syndrome · Autism Spectrum Disorders
Primary: Clinical Global Impression- Severity Scale (CGI-S) — 7.0 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=31 Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence
Cocaine Dependence
Primary: Functional MRI Activation Patterns in the Nucleus Accumbens and Amygdala in Response to Cocaine Cues
Phase 2 N=152 Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Diabetic Macular Edema
Primary: Deaths Due to Myocardial Infarction — 1; 3 participants
Phase 2 N=38 Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea
Dysmenorrhea
Primary: Change in Visual Analog Scale (VAS) Score — -74.8; -58.7 units on a scale — p=0.05
Phase 2 N=22 Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Multiple Sclerosis, Relapsing-Remitting
Primary: Change in the Number of New or Newly Enlarging T2 Hyperintense Lesions on Brain Magnetic Resonance Imaging (MRI) Scans From the Baseline Period to On-Treatment…
Phase 2 N=48 Does Continued Use of Clopidogrel Into Surgery Cause Increased Perioperative Bleeding?
Clopidogrel
Primary: Bleeding-related Re-hospitalization — 1; 1 participants
Phase 2 N=34 Olanzapine in the Treatment of Patients With Anorexia Nervosa
Anorexia Nervosa
Primary: Body Mass Index (BMI) (kg/m^2) — 19.66; 20.30; 19.66; 20.30 kg/m^2
Phase 2 N=114 Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
Adult Acute Myeloid Leukemia in Remission · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Primary: 2 Year Disease Free Survival In Unrelated Donor Recipient Group — 40 percentage of participants
Phase 2 N=35 Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
Hypertension
Primary: 24-hour Average Systolic Blood Pressure — 127; 127; 126; 129 mmHg — p=0.07
Phase 2 N=298 A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02
Systemic Lupus Erythematosus
Primary: Number of Participants With the Indicated Type of Adverse Event (AEs) and Serious Adverse Event (SAEs) — 294; 291; 283; 260 Participants
Phase 2 N=279 A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Crohn's Disease
Primary: Percentage of Participants in Clinical Remission (as Defined by a Crohn's Disease Activity Index [CDAI] Score of Less Than [<] 150 Points) at Week 8 — 36.67; 43.53…
Phase 2 N=10 Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
Cardiac Arrest · Sudden Cardiac Arrest
Primary: Prevalence of Low Serum CoQ10 Levels in Cardiac Arrest Patients — 0.706; 0.66 ug/mL
Phase 2 N=60 Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
Ocular Inflammation and Pain
Primary: Absence of Cells in Anterior Chamber of Study Eye — 6; 3 Participants
Phase 2 N=185 PT003 MDI Dose Confirmation Study
Chronic Obstructive Pulmonary Disease
Primary: FEV1 AUC0-12 — 1.467; 1.462; 1.493; 1.499 Liters
Phase 2 N=23 Effect of Race on Gonadotropin Responses
Premenopause · Healthy
Primary: LH Peak in Response to Estrogen Positive Feedback — 80.3; 73.1 IU/L — p=0.69